Maternal interleukin-6

Marker of fetal growth and adiposity

Tatjana Radaelli, Jennifer Uvena-Celebrezze, Judi Minium, Larraine Huston-Presley, Patrick Catalano, Sylvie Hauguel-de Mouzon

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Fetal overgrowth and higher adiposity are hallmarks of pregnancy with maternal obesity and poor glucose tolerance, two conditions associated with decreased maternal insulin sensitivity. In non-pregnant individuals, adipokines, vasoactive peptides, and components of the immune system crosstalk with metabolic factors to generate signals triggering obesity and impaired insulin action. We have investigated circulating maternal and fetal cytokines and growth-factors as potential biochemical markers of fetal adiposity. Mothers and neonates were classified into three tertiles (T1-T3) using total neonatal fat mass as the outcome with 309 ± 25 g in T1, 478 ± 40 g in T2, and 529 ± 39 g in T3. Umbilical cord endothelin-1 (ET-1), C-peptide, and leptin were higher in T3 and T2 versus T1. Only cord leptin was strongly associated with fetal fat mass (P

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalJournal of the Society for Gynecologic Investigation
Volume13
Issue number1
DOIs
Publication statusPublished - Jan 2006

Fingerprint

Adiposity
Fetal Development
Interleukin-6
Mothers
Leptin
Obesity
Fats
Adipokines
C-Peptide
Umbilical Cord
Endothelin-1
Insulin Resistance
Immune System
Intercellular Signaling Peptides and Proteins
Biomarkers
Insulin
Cytokines
Glucose
Pregnancy
Peptides

Keywords

  • Cytokines
  • Fetal adiposity
  • Growth factors
  • Obesity
  • Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Radaelli, T., Uvena-Celebrezze, J., Minium, J., Huston-Presley, L., Catalano, P., & Hauguel-de Mouzon, S. (2006). Maternal interleukin-6: Marker of fetal growth and adiposity. Journal of the Society for Gynecologic Investigation, 13(1), 53-57. https://doi.org/10.1016/j.jsgi.2005.10.003

Maternal interleukin-6 : Marker of fetal growth and adiposity. / Radaelli, Tatjana; Uvena-Celebrezze, Jennifer; Minium, Judi; Huston-Presley, Larraine; Catalano, Patrick; Hauguel-de Mouzon, Sylvie.

In: Journal of the Society for Gynecologic Investigation, Vol. 13, No. 1, 01.2006, p. 53-57.

Research output: Contribution to journalArticle

Radaelli, T, Uvena-Celebrezze, J, Minium, J, Huston-Presley, L, Catalano, P & Hauguel-de Mouzon, S 2006, 'Maternal interleukin-6: Marker of fetal growth and adiposity', Journal of the Society for Gynecologic Investigation, vol. 13, no. 1, pp. 53-57. https://doi.org/10.1016/j.jsgi.2005.10.003
Radaelli, Tatjana ; Uvena-Celebrezze, Jennifer ; Minium, Judi ; Huston-Presley, Larraine ; Catalano, Patrick ; Hauguel-de Mouzon, Sylvie. / Maternal interleukin-6 : Marker of fetal growth and adiposity. In: Journal of the Society for Gynecologic Investigation. 2006 ; Vol. 13, No. 1. pp. 53-57.
@article{26ec4ef760ba4239b8371f498756ed83,
title = "Maternal interleukin-6: Marker of fetal growth and adiposity",
abstract = "Fetal overgrowth and higher adiposity are hallmarks of pregnancy with maternal obesity and poor glucose tolerance, two conditions associated with decreased maternal insulin sensitivity. In non-pregnant individuals, adipokines, vasoactive peptides, and components of the immune system crosstalk with metabolic factors to generate signals triggering obesity and impaired insulin action. We have investigated circulating maternal and fetal cytokines and growth-factors as potential biochemical markers of fetal adiposity. Mothers and neonates were classified into three tertiles (T1-T3) using total neonatal fat mass as the outcome with 309 ± 25 g in T1, 478 ± 40 g in T2, and 529 ± 39 g in T3. Umbilical cord endothelin-1 (ET-1), C-peptide, and leptin were higher in T3 and T2 versus T1. Only cord leptin was strongly associated with fetal fat mass (P",
keywords = "Cytokines, Fetal adiposity, Growth factors, Obesity, Pregnancy",
author = "Tatjana Radaelli and Jennifer Uvena-Celebrezze and Judi Minium and Larraine Huston-Presley and Patrick Catalano and {Hauguel-de Mouzon}, Sylvie",
year = "2006",
month = "1",
doi = "10.1016/j.jsgi.2005.10.003",
language = "English",
volume = "13",
pages = "53--57",
journal = "Journal of the Society for Gynecologic Investigation",
issn = "1071-5576",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Maternal interleukin-6

T2 - Marker of fetal growth and adiposity

AU - Radaelli, Tatjana

AU - Uvena-Celebrezze, Jennifer

AU - Minium, Judi

AU - Huston-Presley, Larraine

AU - Catalano, Patrick

AU - Hauguel-de Mouzon, Sylvie

PY - 2006/1

Y1 - 2006/1

N2 - Fetal overgrowth and higher adiposity are hallmarks of pregnancy with maternal obesity and poor glucose tolerance, two conditions associated with decreased maternal insulin sensitivity. In non-pregnant individuals, adipokines, vasoactive peptides, and components of the immune system crosstalk with metabolic factors to generate signals triggering obesity and impaired insulin action. We have investigated circulating maternal and fetal cytokines and growth-factors as potential biochemical markers of fetal adiposity. Mothers and neonates were classified into three tertiles (T1-T3) using total neonatal fat mass as the outcome with 309 ± 25 g in T1, 478 ± 40 g in T2, and 529 ± 39 g in T3. Umbilical cord endothelin-1 (ET-1), C-peptide, and leptin were higher in T3 and T2 versus T1. Only cord leptin was strongly associated with fetal fat mass (P

AB - Fetal overgrowth and higher adiposity are hallmarks of pregnancy with maternal obesity and poor glucose tolerance, two conditions associated with decreased maternal insulin sensitivity. In non-pregnant individuals, adipokines, vasoactive peptides, and components of the immune system crosstalk with metabolic factors to generate signals triggering obesity and impaired insulin action. We have investigated circulating maternal and fetal cytokines and growth-factors as potential biochemical markers of fetal adiposity. Mothers and neonates were classified into three tertiles (T1-T3) using total neonatal fat mass as the outcome with 309 ± 25 g in T1, 478 ± 40 g in T2, and 529 ± 39 g in T3. Umbilical cord endothelin-1 (ET-1), C-peptide, and leptin were higher in T3 and T2 versus T1. Only cord leptin was strongly associated with fetal fat mass (P

KW - Cytokines

KW - Fetal adiposity

KW - Growth factors

KW - Obesity

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=29344456405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29344456405&partnerID=8YFLogxK

U2 - 10.1016/j.jsgi.2005.10.003

DO - 10.1016/j.jsgi.2005.10.003

M3 - Article

VL - 13

SP - 53

EP - 57

JO - Journal of the Society for Gynecologic Investigation

JF - Journal of the Society for Gynecologic Investigation

SN - 1071-5576

IS - 1

ER -